Vir Biotechnology is a company focused on developing therapies to prevent and treat infectious diseases. It designs and develops monoclonal antibodies, vaccines, and antiviral therapies targeting pathogens such as influenza, hepatitis B, and SARS-CoV-2. The company serves the healthcare and biopharmaceutical industries.